Coare Biotechnology (United States)

Recent papers from Coare Biotechnology (United States)

1. DCLK1 Monoclonal Antibody-Based CAR-T Cells as a Novel Treatment Strategy against Human Colorectal CancersCancers · 2019
2. Alternative splice variants of DCLK1 mark cancer stem cells, promote self‐renewal and drug‐resistance, and can be targeted to inhibit tumorigenesis in kidney cancerInternational Journal of Cancer · 2018
3. Intestinal tuft cells regulate the ATM mediated DNA Damage response via Dclk1 dependent mechanism for crypt restitution following radiation injuryScientific Reports · 2016
4. Survival of Patients with Gastrointestinal Cancers Can Be Predicted by a Surrogate microRNA Signature for Cancer Stem–like Cells Marked by DCLK1 KinaseCancer Research · 2016
5. Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanismOncotarget · 2015
6. Dclk1+ small intestinal epithelial tuft cells display the hallmarks of quiescence and self-renewalOncotarget · 2015
7. Ablation of Doublecortin-Like Kinase 1 in the Colonic Epithelium Exacerbates Dextran Sulfate Sodium-Induced ColitisPLoS ONE · 2015
8. Dietary Pectin Increases Intestinal Crypt Stem Cell Survival following Radiation InjuryPLoS ONE · 2015
9. Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseasesOncotarget · 2015
10. Doublecortin-Like Kinase 1 Is Elevated Serologically in Pancreatic Ductal Adenocarcinoma and Widely Expressed on Circulating Tumor CellsPLoS ONE · 2015
11. DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinomaOncotarget · 2014
12. DCLK1 Regulates Pluripotency and Angiogenic Factors via microRNA-Dependent Mechanisms in Pancreatic CancerPLoS ONE · 2013